Skip to main content
Equibles
ALNY $231.18 -6.31%
ALNY logo
ALNY · Alnylam Pharmaceuticals, Inc.
Track ALNY — free

Use ALNY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALNY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$231.18 -15.56 (-6.31%) At close · Oct 1
Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$34.17B
Shares
133.81M
Volume · Oct 1 2.02M Avg daily vol (3M) 1.82M
All webcasts

Earnings call · FY2019 Q4

Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2019 Earnings Call

Concluded Feb 6, 2020
Feb 6, 2020 0 turns
Period
FY2019 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $71.68M +240.8% YoY
Net income -$276.19M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 6, 2020 10-K report Filed Feb 13, 2020
Full-screen source Call document

ALNY transcript alerts

Alnylam Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →